CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-09 | SCHIMMEL PAUL Director | Purchase | +317,999 | $0.94 | $299K | 1,413,023 |
| 2025-10-08 | SCHIMMEL PAUL Director | Purchase | +682,001 | $0.90 | $612K | 1,095,024 |
| 2025-05-01 | Zaknoen Sara Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-05-01 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-05-01 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-05-01 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-05-01 | BENEVICH ERIC Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-05-01 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-17 | Gross Jane A Director | Purchase | +3,750 | $4.00 | $15K | 9,750 |
| 2025-02-04 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,254 | $3.78 | $5K | 31,763 |
| 2025-02-04 | DENYES NANCY General Counsel | Sale | −899 | $3.78 | $3K | 26,555 |
| 2025-02-03 | Shukla Sanjay President and CEO | Option exercise | +10,375 | 146,923 | ||
| 2025-02-03 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −10,375 | 10,375 | ||
| 2025-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +3,750 | 33,017 | ||
| 2025-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,750 | 3,750 | ||
| 2025-02-03 | DENYES NANCY General Counsel | Option exercise | +2,687 | 27,454 | ||
| 2025-02-03 | DENYES NANCY General Counsel | Option exercise · Restricted Stock Unit | −2,687 | 2,687 | ||
| 2025-01-08 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2025-01-08 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2025-01-08 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +275,000 | 275,000 |
Page 2 of 15 · 284 trades